IFP Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Other funds holding PBE
GKWIM
CW
YIA
IFWM
IFP Advisors's PBE Position: Q2 2023 in Review
IFP Advisors sold out of Invesco Biotechnology & Genome ETF (PBE) in Q2 2023, closing a stake of 14 shares — an estimated $729 sold.
IFP Advisors first reported a position in PBE in Q4 2015 and held it in 20 quarters. The position peaked at $135K in Q1 2018. 96 funds tracked by Wall St. Rank hold PBE as of Q2 2023.
- IFP Advisors reported no remaining Invesco Biotechnology & Genome ETF position as of Q2 2023 after selling out during the quarter.
- IFP Advisors sold 14 Invesco Biotechnology & Genome ETF shares in Q2 2023, an estimated $729.
- IFP Advisors first reported a position in Invesco Biotechnology & Genome ETF in Q4 2015 and held it in 20 quarters.
- IFP Advisors's Invesco Biotechnology & Genome ETF position peaked at $135K in Q1 2018.
- 96 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2023.
Based on IFP Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.